In Case You Missed It! March 2024

This newsletter highlights a selection of recently published peer-reviewed articles that piqued our interest, grouped by their most relative modality.

We hope you find these recent findings useful and of value in your day-to-day practice.

Home Hemodialysis (HHD) Recent Findings

Patient Survival with Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis

Patient survival, technique survival, hospitalization, and clinical, laboratory, and medication changes were retrospectively analyzed in 349 HHD patients treated with longer session duration, most on nocturnal, were compared to 1,047 concurrent, propensity-score matched in-center hemodialysis patients, using 47 variables with a long-term follow-up.

Learn More

In Case You Missed It! February 2024

This newsletter highlights a selection of recently published peer-reviewed articles that piqued our interest, grouped by their most relative modality.

We hope you find these recent findings useful and of value in your day-to-day practice.

Home Hemodialysis Recent Findings

Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation

Therapeutic vancomycin and daptomycin levels were analyzed in 5,000 simulated home hemodialysis (HHD) patients.  Initial vancomycin and daptomycin doses were defined for 10 common HHD treatment regimens based on HHD treatment duration, days per week, and dialysate volume.

Learn More